Literature DB >> 4067598

Sulfate and glucuronide conjugates of 3-methoxy-4-hydroxyphenylglycol (MHPG) in urine of depressed patients: central and peripheral influences.

L Peyrin, J M Pequignot, G Chauplannaz, B Laurent, G Aimard.   

Abstract

A number of arguments support the hypothesis that changes in urinary levels of MHPG sulfate and MHPG glucuronide respectively reflect central and peripheral norepinephrine metabolism (NE) in man. In this line, the daily excretion of both conjugates was determined in 36 depressed women comparatively to 23 healthy women in order to assess the extent and the central or peripheral location of their possible NE dysfunction. About 80% of the patients suffering from depression (6 endogenous, 19 neurotic, 11 reactive depressions) exhibited a central NE defect, as evidenced by low MHPG sulfate, and many of them had probably also diminished sympathetic activity, as suggested by low MHPG glucuronide. Clinical symptoms possibly related to the psychic state (mood alteration) or associated to sympathetic changes (anxiety, motor activity) respectively altered sulfate or glucuronide excretion. Sulfate (S) and glucuronide (G) MHPG excretions were significantly correlated in healthy subjects (r = 0.53, p = 0.01), thus supporting the concept of the functional link between central NE activity and sympathetic function. Such a correlation was not found in depressive patients. However the lack of significant changes in the mean ratio S/G in the patient sub-groups suggests that as in normal subjects, central and peripheral NE activity are linked in depressed patients, but other factors may also modify sympathetic function. Taken together our data show that the separate assay of sulfate and glucuronide MHPG provides a better picture of NE dysfunction in depression than total MHPG measurement.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067598     DOI: 10.1007/BF01252030

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  42 in total

1.  Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities.

Authors:  F Deleon-Jones; J W Maas; H Dekirmenjian; J Sanchez
Journal:  Am J Psychiatry       Date:  1975-11       Impact factor: 18.112

2.  Effect of physical activity on urinary M.H.P.G. excretion in depressed patients.

Authors:  M H Ebert; R M Post; F K Goodwin
Journal:  Lancet       Date:  1972-10-07       Impact factor: 79.321

3.  The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome.

Authors:  P Riederer; W Birkmayer; E Neumayer; L Ambrozi; W Linauer
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

4.  Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

Authors:  S M Schanberg; J J Schildkraut; G R Breese; I J Kopin
Journal:  Biochem Pharmacol       Date:  1968-02       Impact factor: 5.858

5.  In vivo studies of the metabolism of norepinephrine in the central nervous system.

Authors:  J W Maas; D H Landis
Journal:  J Pharmacol Exp Ther       Date:  1968-09       Impact factor: 4.030

Review 6.  4-hydroxy-3-methoxyphenylglycol as an index of brain noradrenaline turnover in endogenous depression.

Authors:  P Riederer; W Birkmayer; D Seemann; S Wuketich
Journal:  Acta Psychiatr Scand Suppl       Date:  1980

7.  Diagnostic criteria for use in psychiatric research.

Authors:  J P Feighner; E Robins; S B Guze; R A Woodruff; G Winokur; R Munoz
Journal:  Arch Gen Psychiatry       Date:  1972-01

8.  Urinary MHPG, stress response, personality factors and somatosensory evoked potentials in normal subjects and patients with major affective disorders.

Authors:  M S Buchsbaum; G Muscettola; F K Goodwin
Journal:  Neuropsychobiology       Date:  1981       Impact factor: 2.328

9.  Covariance of plasma free 3-methoxy-4-hydroxyphenethyleneglycol and diastolic blood pressure.

Authors:  J F Leckman; J W Maas; G R Heninger
Journal:  Eur J Pharmacol       Date:  1981-03-12       Impact factor: 4.432

10.  Free and conjugated 3-methoxy-4-hydroxyphenylglycol in human urine: peripheral origin of glucuronide.

Authors:  L Peyrin; J M Pequignot
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more
  5 in total

1.  Comparison of a 4-day confinement and head-down tilt on endocrine response and cardiovascular variability in humans.

Authors:  D Sigaudo; J O Fortrat; A Maillet; A M Allevard; A Pavy-Le Traon; R L Hughson; A Guell; C Gharib; G Gauquelin
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 2.  Urinary MHPG sulfate as a marker of central norepinephrine metabolism: a commentary.

Authors:  L Peyrin
Journal:  J Neural Transm Gen Sect       Date:  1990

3.  A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites.

Authors:  Li Xie; Liqin Chen; Pan Gu; Lanlan Wei; Xuejun Kang
Journal:  J Vis Exp       Date:  2018-03-01       Impact factor: 1.355

4.  Effect of cytidine(5')diphosphocholine (CDP-choline) on the total urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) by rats and humans.

Authors:  I Lopez; G Coviella; J Agut; R J Wurtman
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

5.  Relationships between catecholamine or 3-methoxy 4-hydroxy phenylglycol changes and the mental performance under submaximal exercise in man.

Authors:  L Peyrin; J M Pequignot; J R Lacour; J Fourcade
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.